RFS
FOLD

Rockefeller Financial Services’s Amicus Therapeutics FOLD Stock Holding History

Rockefeller Financial Services’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$276K Buy
+19,169
New +$263K ﹤0.01% 318
2017
Q2 		– Sell
-19,093
Closed -$136K – 451
2017
Q1 		$136K Buy
+19,093
New +$121K ﹤0.01% 335
2015
Q4 		– Sell
-19,012
Closed -$266K – 547
2015
Q3 		$266K Sell
19,012
-1,111
-6% -$17.4K 0.01% 304
2015
Q2 		$285K Buy
+20,123
New +$242K 0.01% 285

Other funds holding FOLD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Rockefeller Financial Services's FOLD Position: Q4 2017 in Review

Rockefeller Financial Services opened a new position in Amicus Therapeutics (FOLD) in Q4 2017: 19,169 shares worth $276K. The stake represents ﹤0.01% of the portfolio and ranks #318 among its holdings. This is a return to the name: Rockefeller Financial Services previously reported a position in FOLD as recently as Q1 2017.

Rockefeller Financial Services first reported a position in FOLD in Q2 2015 and has held it in 4 quarters since. The position peaked at $285K in Q2 2015. 185 funds tracked by Wall St. Rank hold FOLD as of Q4 2017.

  • Rockefeller Financial Services held 19,169 shares of Amicus Therapeutics worth $276K as of Q4 2017.
  • Amicus Therapeutics was a new Rockefeller Financial Services position in Q4 2017.
  • Amicus Therapeutics made up ﹤0.01% of Rockefeller Financial Services's portfolio in Q4 2017, its #318 holding.
  • Rockefeller Financial Services first reported a position in Amicus Therapeutics in Q2 2015 and has held it in 4 quarters since.
  • Rockefeller Financial Services's Amicus Therapeutics position peaked at $285K in Q2 2015.
  • 185 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q4 2017.

Based on Rockefeller Financial Services's 13F filing for Q4 2017, filed 2 Feb 2018.